Urticaria pigmentosa is a skin condition caused by an abnormal buildup of mast cells, a type of immune cell, in the skin. It produces small, reddish-brown or yellowish-brown spots that itch and can swell into hives when rubbed or irritated. It’s the most common form of cutaneous mastocytosis, estimated to affect roughly 1 in 10,000 people, though that number is likely higher due to underdiagnosis.
How It Relates to Mastocytosis
Mast cells are part of your immune system. They sit in your skin and other tissues, releasing chemicals like histamine when they detect a threat. In urticaria pigmentosa, too many mast cells accumulate in the skin, and they’re overly reactive. The World Health Organization classifies urticaria pigmentosa (now formally called maculopapular cutaneous mastocytosis) as one of three forms of skin-limited mastocytosis, alongside diffuse cutaneous mastocytosis and localized mastocytoma.
The skin-only form is distinct from systemic mastocytosis, where mast cells accumulate in internal organs like bone marrow, the liver, or the spleen. However, the two aren’t completely separate. About 80% of people with systemic mastocytosis also have the characteristic skin lesions. In adults, doctors typically evaluate whether the condition extends beyond the skin, since adult-onset cases carry a higher likelihood of systemic involvement than childhood cases.
What the Skin Lesions Look Like
The spots are typically small, flat or slightly raised, and tan to brown in color. They range from a few scattered spots to dozens or even hundreds. Most are about 1 to 2 centimeters across, though some grow larger. They appear mainly on the trunk (chest, abdomen, and back) and tend to spare the central face, palms, and soles.
What sets these spots apart from ordinary freckles or moles is their behavior. When you rub or scratch one, the mast cells inside release histamine, causing the spot to swell into a red, raised hive. This reaction is called Darier’s sign, and it’s one of the hallmarks doctors look for. During a clinical exam, a physician may stroke a lesion with a blunt object like a capped pen for about 10 seconds. If the spot welts up with redness, swelling, and sometimes even a small blister, the sign is positive. Most people with mastocytosis exhibit it.
Triggers That Cause Flares
Because the core problem is mast cells that release their chemicals too easily, many everyday exposures can trigger itching, flushing, and swelling of the spots. Common triggers include friction from clothing, hot baths or showers, vigorous exercise, emotional stress, sudden temperature changes, and certain medications (particularly NSAIDs and some anesthetics). Alcohol and spicy foods can also provoke symptoms in some people. Learning your individual triggers and avoiding them is one of the most practical steps in managing the condition day to day.
How It’s Diagnosed
A positive Darier’s sign during a physical exam is a strong clue, but a skin biopsy confirms the diagnosis. Under a microscope, the biopsy shows focal accumulations of mast cells in the dermis at levels more than five times above normal. These cells often cluster around blood vessels. A special stain called toluidine blue highlights the mast cells, making them easier to count and identify.
Once the skin diagnosis is confirmed, doctors often run additional tests in adults to check whether mast cells have accumulated elsewhere in the body. This may include blood work looking at a marker called serum tryptase and, in some cases, a bone marrow biopsy. For children, this level of workup is usually unnecessary unless symptoms suggest systemic involvement.
Children vs. Adults: Different Outlook
Urticaria pigmentosa behaves very differently depending on when it starts. In children, the condition often appears in the first two years of life and tends to improve over time. Lesions commonly fade or resolve entirely by late adolescence or early adulthood. One long-term follow-up study found that about two-thirds of pediatric patients experienced complete regression of both skin lesions and symptoms roughly 20 years later. The often-cited estimate is that about 50% of childhood cases resolve by puberty, though the true number may be higher with longer follow-up.
Adult-onset urticaria pigmentosa is a different story. It rarely resolves on its own and is more likely to be associated with systemic mastocytosis. Adults diagnosed with skin lesions are typically evaluated more thoroughly for internal organ involvement, and they generally need ongoing management rather than a wait-and-see approach.
First-Line Treatment: Antihistamines
There is no cure for urticaria pigmentosa, but symptoms can be controlled effectively in most people. The foundation of treatment is antihistamines. Non-sedating H1 antihistamines (the same type used for seasonal allergies) are the first choice for managing itching, flushing, and the burning sensation that comes with flares.
If those aren’t enough at maximum doses, doctors often add H2 antihistamines, which target a different histamine receptor. H2 blockers are especially helpful when the condition causes gastrointestinal symptoms like stomach cramps, diarrhea, or acid overproduction. A leukotriene blocker, a type of anti-inflammatory medication, can also be layered on for additional relief. Short courses of topical corticosteroid creams are sometimes used to calm individual lesions during flares.
When Antihistamines Aren’t Enough
For people whose symptoms persist despite a full antihistamine regimen, phototherapy is the main second-line option. This involves controlled exposure to ultraviolet light, typically UVA-based treatments. One form, called PUVA therapy (which combines a light-sensitizing medication taken by mouth with UVA light exposure), has shown improvement in about 70% of patients. A quarter of those treated maintained improvement for more than five years, and some benefited for over a decade. Patients who developed the condition during childhood or adolescence and those with lighter skin types tended to respond best.
The duration of benefit varies widely, from a few weeks to many years, and the treatment doesn’t work equally well for everyone. Bath-based PUVA, where the sensitizing agent is dissolved in water instead of taken orally, has shown less promising results.